EBOS Group (EBO.AX)

Overall impact
B (77)

Commentary

EBOS Group is a strong overall performer. With a 'B' rating of 77.5 for overall impact (91st percentile compared to all companies), EBOS Group ranks 1st out of 20 industry peers, ahead of Cardinal Health, JD Health International, Suzuken Co. and 16 others. On top material causes for EBOS Group's industry (Health Care Providers & Services), EBOS Group performs well in Child and Maternal Health (92.9 score), Child and Maternal Health (92.9), Accountable Institutions (94.7) and 15 other causes where it received an 'A' score and performs poorly in Humane Treatment of Animals (36.3 score).
Screens
Fur
Impact
Cause EBO.AX
Peer rank
Overall impact

Log in to view this information

Screens
Fur
Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1922
Employees
5,009
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Distributors
SASB industry
Healthcare Distributors
Headquarters
Vic, Australia
Share classes
EBO.AX
Description
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers allografts solutions; healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
Material causes
Ethos considers the following causes material for EBOS Group, based on its industry sub-industry Health Care Distributors. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.